Skip to content
PubMed This is a summary of 19 peer-reviewed journal articles Updated
Nephrology · Atherosclerotic Renal Artery Stenosis

Understanding Your Diagnosis: Renal Artery Atheroma

At a Glance

Renal artery atheroma is cholesterol plaque that narrows the arteries supplying the kidneys and can raise blood pressure. Most stable cases are managed with blood pressure and cholesterol medicines, lifestyle changes, and monitoring; stents are reserved for selected high-risk situations.

Receiving a diagnosis like renal artery atheroma can feel overwhelming, but it is important to know that for most people, this is a manageable condition rather than an immediate crisis. This diagnosis means that plaque—a buildup of fats and cholesterol—has formed in the arteries that supply blood to your kidneys [1]. While the term sounds complex, it is a localized version of a process that can happen anywhere in the body’s arterial system [2].

What is Renal Artery Atheroma?

Renal artery atheroma, also known as atherosclerotic renal artery stenosis (ARAS), is the narrowing of one or both of the main blood vessels leading to the kidneys [3]. Think of it like a garden hose that has developed some buildup inside; the water can still flow, but the opening is smaller, and the pressure changes. Narrowing can occur in one kidney (unilateral) or both (bilateral).

In the majority of cases, this is not an isolated problem with the kidneys. Instead, it is a sign of systemic atherosclerosis, meaning plaque is likely present in other blood vessels in your body [1]. It often occurs alongside other conditions like coronary artery disease or peripheral artery disease (narrowing in the leg arteries) [4]. Because it is a systemic issue, the risk factors are the same ones that affect heart health:

  • Older age [1]
  • Smoking [4]
  • High cholesterol or high lipoprotein(a) (a specific type of protein that carries cholesterol) [5]
  • Diabetes [4]
  • Existing high blood pressure [1]

How the Kidneys Control Blood Pressure

The kidneys are incredibly sensitive to blood flow. When the renal artery narrows significantly, the kidney on that side receives less blood and lower pressure than it expects. The kidney “interprets” this drop in pressure as a sign that your body’s overall blood pressure is too low—even if it is actually normal or already high [6].

To “fix” this perceived problem, the kidney activates a hormonal chain reaction called the renin-angiotensin-aldosterone system (RAAS) [7]:

  1. The kidney releases a hormone called renin into the bloodstream [6].
  2. Renin triggers the production of other hormones that cause your blood vessels to tighten (vasoconstriction) [7].
  3. These hormones also signal the body to hold onto salt and water [7].

The result is a rise in blood pressure throughout your entire body. This is why renal artery atheroma is a leading cause of renovascular hypertension—high blood pressure caused specifically by the narrowing of the kidney’s blood supply [8].

Understanding the Risks

It is natural to worry about the health of your kidneys or the risk of a stroke. However, the “natural history” of this condition—how it typically progresses over time—is often much slower and more stable than patients fear.

  • Kidney Failure is Uncommon: While the narrowing can reduce kidney function over many years, modern medical management is very effective. Recent large-scale studies show that fewer than 8% of stable trial patients with this condition progress to end-stage kidney disease (ESKD) over several years of follow-up [9][10]. In some major clinical trials of stable populations, the rate of patients needing dialysis was as low as 1.5% to 2% [11].
  • A Focus on the Whole Body: Because this is a systemic vascular condition, the primary goal of treatment is often protecting your heart and brain, not just the kidneys. Controlling your blood pressure and cholesterol significantly reduces the risk of heart attack or stroke [2][12].

Managing Your Diagnosis

For most people, renal artery atheroma is not an emergency. It is a “chronic” condition, meaning it is something you and your doctor will manage over the long term.

Current medical guidelines emphasize optimal medical therapy as the first and most important line of treatment [13][14]. This typically includes:

  • Blood Pressure Medications: Drugs that block the RAAS system (like ACE inhibitors or ARBs) are often used because they directly target the hormonal overreaction caused by the narrowing [15].
  • Cholesterol Management: Statin medications help stabilize the plaque and prevent it from growing or breaking off [12].
  • Antiplatelet Therapy: Medications like aspirin may be recommended based on your overall cardiovascular and bleeding risk to prevent blood clots from forming near the plaque; do not start them without clinician advice [16].
  • Lifestyle Changes: Quitting smoking is one of the most powerful things you can do to protect your kidneys and blood vessels [17].

In the past, doctors frequently used stents to prop open the renal artery. However, multiple large clinical trials (such as CORAL and ASTRAL) found that for most stable patients, adding a stent did not provide better results for blood pressure or kidney function than medical therapy alone [12][18]. Stenting is now usually evaluated for very specific, high-risk situations, such as when blood pressure cannot be controlled with several medications or when kidney function is dropping very rapidly [19][14].

Common questions in this guide

What is renal artery atheroma?
Renal artery atheroma is a buildup of fatty cholesterol plaque in one or both arteries that carry blood to the kidneys. The plaque narrows the artery and is also called atherosclerotic renal artery stenosis. It often reflects atherosclerosis elsewhere in the body, not just a kidney problem.
How can renal artery atheroma cause high blood pressure?
When an artery is narrowed, the affected kidney receives less blood and may interpret this as low body-wide pressure. It releases hormones that tighten blood vessels and make the body retain salt and water, which can raise blood pressure. This is called renovascular hypertension.
Will renal artery atheroma cause kidney failure?
Kidney failure is not inevitable, and stable cases often progress slowly when blood pressure and cardiovascular risks are well controlled. The risk depends on the degree of narrowing, kidney function, and whether the disease is worsening. Regular blood and urine testing can help your clinician detect changes early.
How is renal artery atheroma usually treated?
Treatment usually focuses on medicines and risk-factor control rather than a procedure. Blood-pressure medicines such as ACE inhibitors or ARBs, statins for cholesterol, and lifestyle changes such as stopping smoking may be recommended. Aspirin or another antiplatelet medicine is used only when a clinician judges that the benefits outweigh the bleeding risk.
Do I need a stent for renal artery atheroma?
Most stable patients do not gain better blood pressure or kidney outcomes from a stent than from medical therapy alone. A clinician may consider stenting when blood pressure remains difficult to control despite several medicines or kidney function is falling rapidly. The decision depends on the severity and behavior of the narrowing and your overall health.
What should be monitored after a renal artery atheroma diagnosis?
Ask about your home blood pressure readings, kidney function, and protein in the urine. Your clinician may also follow cholesterol, blood sugar, and the artery narrowing with blood tests or imaging, with timing based on your situation. Report new symptoms such as sudden shortness of breath, leg swelling, or a marked change in urine output.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What is the degree of narrowing in my renal arteries, and are one or both sides affected?
  2. 2.How are my current kidney function (eGFR) and protein levels in my urine?
  3. 3.Is my blood pressure currently at a safe goal, or do we need to adjust my medications?
  4. 4.Are there specific symptoms, like sudden shortness of breath, that I should watch for?
  5. 5.How often will we need to repeat imaging or blood tests to monitor the plaque?
  6. 6.Given my diagnosis, what are my targets for cholesterol and blood sugar?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (19)
  1. 1

    Prevalence and Associated Factors of Atherosclerotic Plaque and Stenosis in Renal Arteries: A Community-Based Study.

    Wang D, Pan Y, Cai X, et al.

    Angiology 2025; (76(8)):751-758 doi:10.1177/00033197241238404.

    PMID: 38451176
  2. 2

    Ultrasonographic Assessment of Atherosclerotic Renal Artery Stenosis in Elderly Patients with Chronic Kidney Disease: An Italian Cohort Study.

    Battaglia Y, Fiorini F, Gisonni P, et al.

    Diagnostics (Basel, Switzerland) 2022; (12(6)) doi:10.3390/diagnostics12061454.

    PMID: 35741264
  3. 3

    Prevalence and predictors of atherosclerotic renal artery stenosis in hypertensive patients undergoing simultaneous coronary and renal artery angiography; a cross-sectional study.

    Payami B, Jafarizade M, Beladi Mousavi SS, et al.

    Journal of renal injury prevention 2016; (5(1)):34-8 doi:10.15171/jrip.2016.08.

    PMID: 27069966
  4. 4

    Renal Artery Stenosis: New Findings from the CORAL Trial.

    Gupta R, Assiri S, Cooper CJ

    Current cardiology reports 2017; (19(9)):75 doi:10.1007/s11886-017-0894-2.

    PMID: 28752274
  5. 5

    Lipoprotein (a) as a residual risk factor for atherosclerotic renal artery stenosis in hypertensive patients: a hospital-based cross-sectional study.

    Hu X, Yang X, Li X, et al.

    Lipids in health and disease 2020; (19(1)):173 doi:10.1186/s12944-020-01272-0.

    PMID: 32703301
  6. 6

    An Outline of Renal Artery Stenosis Pathophysiology-A Narrative Review.

    Dobrek L

    Life (Basel, Switzerland) 2021; (11(3)) doi:10.3390/life11030208.

    PMID: 33799957
  7. 7

    Atherosclerotic renal artery stenosis in the post-CORAL Trial Era. A narrative review.

    Grillo A, Lepidi S, Puato M

    Current problems in cardiology 2026; (51(1)):103205 doi:10.1016/j.cpcardiol.2025.103205.

    PMID: 41167516
  8. 8

    Atherosclerotic renovascular disease and cardiovascular risk: new concepts.

    Januszewicz A, Januszewicz M, Prejbisz A, et al.

    Polish archives of internal medicine 2022; (132(12)) doi:10.20452/pamw.16384.

    PMID: 36533812
  9. 9

    Progress in the treatment of atherosclerotic renovascular disease: the conceptual journey and the unanswered questions.

    Vassallo D, Kalra PA

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2016; (31(10)):1595-605 doi:10.1093/ndt/gfv278.

    PMID: 26187997
  10. 10

    Managing acute presentations of atheromatous renal artery stenosis.

    de Bhailis Á, Al-Chalabi S, Hagemann R, et al.

    BMC nephrology 2022; (23(1)):210 doi:10.1186/s12882-022-02813-8.

    PMID: 35710381
  11. 11

    Early Rapid Decline in Kidney Function in Medically Managed Patients With Atherosclerotic Renal Artery Stenosis.

    Cooper EL, Xie Y, Nguyen H, et al.

    Journal of the American Heart Association 2019; (8(11)):e012366 doi:10.1161/JAHA.119.012366.

    PMID: 31433717
  12. 12

    Effects of Stenting for Atherosclerotic Renal Artery Stenosis on eGFR and Predictors of Clinical Events in the CORAL Trial.

    Tuttle KR, Dworkin LD, Henrich W, et al.

    Clinical journal of the American Society of Nephrology : CJASN 2016; (11(7)):1180-1188 doi:10.2215/CJN.10491015.

    PMID: 27225988
  13. 13

    Atherosclerotic renovascular disease: a clinical practice document by the European Renal Best Practice (ERBP) board of the European Renal Association (ERA) and the Working Group Hypertension and the Kidney of the European Society of Hypertension (ESH).

    Sarafidis PA, Theodorakopoulou M, Ortiz A, et al.

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2023; (38(12)):2835-2850 doi:10.1093/ndt/gfad095.

    PMID: 37202218
  14. 14

    Atherosclerotic Renovascular Disease: A KDIGO (Kidney Disease: Improving Global Outcomes) Controversies Conference.

    Hicks CW, Clark TWI, Cooper CJ, et al.

    American journal of kidney diseases : the official journal of the National Kidney Foundation 2022; (79(2)):289-301 doi:10.1053/j.ajkd.2021.06.025.

    PMID: 34384806
  15. 15

    Revascularization of atherosclerotic renal artery stenosis in patients with heart failure.

    Green D, Cleland JGF, Pellicori P, et al.

    European journal of heart failure 2026; doi:10.1093/ejhf/xuag042.

    PMID: 41771107
  16. 16

    Renal artery stenosis.

    Safian RD

    Progress in cardiovascular diseases 2021; (65()):60-70 doi:10.1016/j.pcad.2021.03.003.

    PMID: 33745915
  17. 17

    Cigarette smoking and cardio-renal events in patients with atherosclerotic renal artery stenosis.

    Drummond CA, Brewster PS, He W, et al.

    PloS one 2017; (12(3)):e0173562 doi:10.1371/journal.pone.0173562.

    PMID: 28306749
  18. 18

    Long Term Outcomes After Renal Revascularization for Atherosclerotic Renovascular Disease in the ASTRAL Trial.

    O'Keeffe H, Green D, de Bhailis A, et al.

    Circulation. Cardiovascular interventions 2024; (17(9)):e013979 doi:10.1161/CIRCINTERVENTIONS.123.013979.

    PMID: 39145377
  19. 19

    Review of Renal Artery Stenosis and Hypertension: Diagnosis, Management, and Recent Randomized Control Trials.

    Arab SF, Alhumaid AA, Abu Alnasr MT, et al.

    Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia 2022; (33(1)):147-159 doi:10.4103/1319-2442.367807.

    PMID: 36647988

This page is for informational purposes only and does not constitute medical advice about renal artery atheroma. Your clinician should interpret your artery narrowing, kidney function, blood pressure, and treatment options.

Get notified when new evidence is published on renal artery atheroma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.